RIGEL PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Rigel Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q4 2023.
  • Rigel Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 175M shares, a 0.82% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 175M +1.43M +0.82% Dec 31, 2023 10-K 2024-03-05
Q4 2022 173M +1.8M +1.05% Dec 31, 2022 10-K 2024-03-05
Q4 2021 172M +2.29M +1.35% Dec 31, 2021 10-K 2023-03-07
Q4 2020 169M +1.33M +0.79% Dec 31, 2020 10-K 2022-03-01
Q4 2019 168M +816K +0.49% Dec 31, 2019 10-K 2021-03-02
Q4 2018 167M +20.4M +13.9% Dec 31, 2018 10-K 2020-02-27
Q4 2017 147M +47.5M +47.9% Dec 31, 2017 10-K 2019-02-28
Q4 2016 99.3M +8.71M +9.62% Dec 31, 2016 10-K 2018-03-06
Q4 2015 90.6M +2.51M +2.86% Dec 31, 2015 10-K 2017-03-07
Q4 2014 88M +517K +0.59% Dec 31, 2014 10-K 2016-03-08
Q4 2013 87.5M +384K +0.44% Dec 31, 2013 10-K 2015-03-03
Q4 2012 87.1M +15.8M +22.1% Dec 31, 2012 10-K 2014-03-04
Q3 2012 71.8M +527K +0.74% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 71.6M +392K +0.55% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 71.5M Mar 31, 2012 10-Q 2012-05-01
Q4 2011 71.4M +19.1M +36.6% Dec 31, 2011 10-K 2013-03-05
Q3 2011 71.2M Sep 30, 2011 10-Q 2011-11-01
Q2 2011 71.2M Jun 30, 2011 10-Q 2011-08-02
Q4 2010 52.3M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.